Pharmacokinetic/pharmacodynamic models for the depletion of Vbeta5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACS
about
Pharmacodynamic models for discrete data.Preconditioning of Nonlinear Mixed Effects Models for Stabilisation of Variance-Covariance Matrix ComputationsImportance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions.An automated sampling importance resampling procedure for estimating parameter uncertainty.Population exposure-safety analysis of cediranib for Phase I and II studies in patients with cancer.
P2860
Pharmacokinetic/pharmacodynamic models for the depletion of Vbeta5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACS
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacokinetic/pharmacodynami ...... sclerosis, as measured by FACS
@ast
Pharmacokinetic/pharmacodynami ...... sclerosis, as measured by FACS
@en
type
label
Pharmacokinetic/pharmacodynami ...... sclerosis, as measured by FACS
@ast
Pharmacokinetic/pharmacodynami ...... sclerosis, as measured by FACS
@en
prefLabel
Pharmacokinetic/pharmacodynami ...... sclerosis, as measured by FACS
@ast
Pharmacokinetic/pharmacodynami ...... sclerosis, as measured by FACS
@en
P2093
P2860
P1476
Pharmacokinetic/pharmacodynami ...... sclerosis, as measured by FACS
@en
P2093
Charlotte Edenius
Mats O Karlsson
Per-Henrik Zingmark
P2860
P304
P356
10.1111/J.1365-2125.2004.02177.X
P407
P577
2004-10-01T00:00:00Z